CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Valenta Farmatsevtika AO is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Valenta Farmatsevtika AO
ul. Fabrichnaya, d.2
Phone: +7 4959336080p:+7 4959336080 SHCHELKOVO, 141108  Russian Federation Fax: +7 4959336081f:+7 4959336081
This is a Subsidiary, click here for the Parent Company
Business Summary
Valenta Farmatsevtika AO, formerly Valenta Farmatsevtika PAO, is a Russia-based pharmaceutical company. The Company is engaged in development, production, and market launch of prescription and Over-the-counter (OTC) medicines for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology and urology, among others. The Company's main medicines portfolio comprises brands as Ingaverin, Grammidin, Trimedat, Teraligen, Phenazepamum, Pantocalcin and Aminazine. The Company's research and production facility locates at the Schyolkovo site. Its operations cover about 56 regions of Russia, as well as Belarus, Kyrgyzstan, Azerbaijan, Armenia and Uzbekistan.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201712/31/2016Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Advisor to the General Director for Business Development Kirill K.Syrov 48 1/1/2012 1/1/2009
General Director (CEO) Anton E.Strekalov 44 10/1/2013 1/1/2008
Chief Accountant Galina G.Korkishko 53
8 additional Officers and Directors records available in full report.

Business Names
Business Name
SHVZ
Valenta Farm OAO
Valenta Farmatsevtika OAO (P)
Valenta Pharm
Valenta Pharmaceuticals OJSC

General Information
Number of Employees: 1,194 (As of 9/30/2013)
Outstanding Shares: 1,145,500 (As of 6/30/2017)
Shareholders: 366
Stock Exchange: RTB
Fax Number: +7 4959336081


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023